BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24147454)

  • 1. Education and imaging. Gastrointestinal: severe inflammatory bowel disease-associated pyoderma gangrenosum.
    Freedberg DE; Husain S; Swaminath A
    J Gastroenterol Hepatol; 2013 Nov; 28(11):1691. PubMed ID: 24147454
    [No Abstract]   [Full Text] [Related]  

  • 2. [Ulcerative colitis associated with pyoderma gangrenosum].
    Tusnádi A; Uhrin K; Bényei M; Krasznai G
    Orv Hetil; 1994 Apr; 135(17):917-9. PubMed ID: 7909938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response to infliximab in atypical pyoderma gangrenosum associated with ulcerative colitis.
    Fernández A; Velasco A; Prieto V; Canueto J; Alvarez A; Rodríguez A
    Am J Gastroenterol; 2008 Nov; 103(11):2951-2. PubMed ID: 19032482
    [No Abstract]   [Full Text] [Related]  

  • 4. Image of the Month. Pyoderma gangrenosum caused by ulcerative colitis.
    Botros N; Pickover L; Das KM
    Gastroenterology; 2000 Apr; 118(4):654, 809. PubMed ID: 10777349
    [No Abstract]   [Full Text] [Related]  

  • 5. All that is red is not cellulitis. Pyoderma gangrenosum.
    Sharma P; Dhungel S
    Eur J Intern Med; 2014 Feb; 25(2):e17-8. PubMed ID: 24393443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refractory pyoderma gangrenosum associated with ulcerative colitis successfully treated with infliximab.
    Ueda M; Katoh M; Tanizaki H; Tanioka M; Matsumura Y; Miyachi Y
    Dermatol Online J; 2012 Jan; 18(1):12. PubMed ID: 22301049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma gangrenosum treated with infliximab in inactive ulcerative colitis.
    Ermis F; Ozdil S; Akyüz F; Pinarbasi B; Mungan Z
    Inflamm Bowel Dis; 2008 Nov; 14(11):1611-3. PubMed ID: 18401859
    [No Abstract]   [Full Text] [Related]  

  • 8. [What is your diagnosis? Pyoderma gangrenosum].
    Wieler B; Vorburger D; Lindenmann N
    Praxis (Bern 1994); 2009 Dec; 98(25):1497-8. PubMed ID: 20013685
    [No Abstract]   [Full Text] [Related]  

  • 9. PYODERMA GANGRENOSUM AS THE ONLY MANIFESTATION OF ASYMPTOMATIC NEWLY DIAGNOSED NONSPECIFIC ULCERATIVE COLITIS. CLINICAL CASE.
    Rosul MV; Patskan BM
    Wiad Lek; 2022; 75(10):2549-2553. PubMed ID: 36472297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment with infliximab of peristomal pyoderma gangrenosum in ulcerative colitis].
    Krag AA; Gjersøe P
    Ugeskr Laeger; 2005 May; 167(18):1968-9. PubMed ID: 15929274
    [No Abstract]   [Full Text] [Related]  

  • 11. Ulcerative colitis with refractory pyoderma gangrenosum.
    Liu FC; Liu NT; Huang TY
    QJM; 2020 Aug; 113(8):567-568. PubMed ID: 32129869
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ulcerative colitis concomitant with pyoderma gangrenosum and erythema nodosum--presentation of two cases].
    Wojas-Pelc A; Wielowieyska-Szybińska D; Setkowicz M; Szybiński P; Bogdaszewska-Czabanowska J
    Przegl Lek; 2001; 58(10):945-9. PubMed ID: 11957826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and treatment of pyoderma gangrenosum in inflammatory bowel disease.
    Argüelles-Arias F; Castro-Laria L; Lobatón T; Aguas-Peris M; Rojas-Feria M; Barreiro-de Acosta M; Soto-Escribano P; Calvo-Moya M; Ginard-Vicens D; Chaparro-Sánchez M; Hernández-Durán M; Castro-Senosiain B; Fernández-Villaverde A; García-Sánchez V; Domínguez-Muñoz E; Caunedo-Álvarez A; Herrerías-Gutiérrez JM
    Dig Dis Sci; 2013 Oct; 58(10):2949-54. PubMed ID: 23828140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyoderma gangrenosum and ulcerative colitis in the tropics.
    Alese OB; Irabor DO
    Rev Soc Bras Med Trop; 2008; 41(6):664-7. PubMed ID: 19142449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant occurrence of pyoderma gangrenosum and erythema nodosum in inflammatory bowel disease.
    Goldberg I; Finkel O; Gat A; Sprecher E; de Morentin HM
    Isr Med Assoc J; 2014 Mar; 16(3):168-70. PubMed ID: 24761705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of infliximab in pyoderma gangrenosum.
    Hewitt D; Tait C
    Australas J Dermatol; 2007 May; 48(2):95-8. PubMed ID: 17535196
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyoderma gangrenosum associated with ulcerative colitis.
    Ljubojević S; Milavec-Puretić V; Sredoja-Tisma V; Rados J; Kalauz M; Hrstić I
    Acta Dermatovenerol Croat; 2006; 14(1):35-9. PubMed ID: 16603100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pyoderma gangrenosum associated with ulcerative colitis and psoriasis.
    Guo H; Zhang L; An Q; Yang ZH; Li B; Gao XH; Li JH
    Chin Med J (Engl); 2013; 126(9):1798. PubMed ID: 23652076
    [No Abstract]   [Full Text] [Related]  

  • 19. Infliximab for the treatment of disseminated pyoderma gangrenosum associated with ulcerative colitis. Case report and literature review.
    Juillerat P; Christen-Zäch S; Troillet FX; Gallot-Lavallée S; Pannizzon RG; Michetti P
    Dermatology; 2007; 215(3):245-51. PubMed ID: 17823524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyoderma gangrenosum: an updated review.
    Ruocco E; Sangiuliano S; Gravina AG; Miranda A; Nicoletti G
    J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1008-17. PubMed ID: 19470075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.